0001883744-21-000001.txt : 20210917 0001883744-21-000001.hdr.sgml : 20210917 20210917150103 ACCESSION NUMBER: 0001883744-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210917 DATE AS OF CHANGE: 20210917 EFFECTIVENESS DATE: 20210917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NapaJen Pharma, Inc. CENTRAL INDEX KEY: 0001883744 IRS NUMBER: 201993612 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-413786 FILM NUMBER: 211260106 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BOULEVARD, SUITE 527 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 81-42-316-6773 MAIL ADDRESS: STREET 1: 533 AIRPORT BOULEVARD, SUITE 527 CITY: BURLINGAME STATE: CA ZIP: 94010 D 1 primary_doc.xml X0708 D LIVE 0001883744 NapaJen Pharma, Inc. 533 AIRPORT BOULEVARD, SUITE 527 BURLINGAME CA CALIFORNIA 94010 81-42-316-6773 CALIFORNIA None None Corporation true Walter Olesiak c/o NapaJen Pharma, Inc. 533 Airport Boulevard, Suite 527 Burlingame CA CALIFORNIA 94010 Executive Officer Director Taro Inaba c/o NapaJen Pharma, Inc. 533 Airport Boulevard, Suite 527 Burlingame CA CALIFORNIA 94010 Director Kazuhiko Nonomura c/o NapaJen Pharma, Inc. 533 Airport Boulevard, Suite 527 Burlingame CA CALIFORNIA 94010 Director Pharmaceuticals Decline to Disclose 06b false 2021-08-24 false true false 0 2000000 500000 1500000 false 1 0 0 0 false NapaJen Pharma, Inc. /s/ Walter Olesiak Walter Olesiak Chief Executive Officer 2021-09-14